BUSINESSBloomberg Markets·13h ago
Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
AI TLDR · GEMINI
Adarx Pharmaceuticals raised $446.3 million in an upsized initial public offering. The gene therapy developer priced the shares at the top of its marketed range.
Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range.
READ NEXT
More on the wire
community11m ago
AI TLDR
Residents in the Russian-occupied city of Oleshky, Ukraine, are facing severe shortages of food and medicine while living under constant attacks.
politics13h ago
AI TLDR
Republican lawmakers are demanding information from the Pentagon after sensitive F-35 equipment was diverted to Hong Kong.
sports15h ago
AI TLDR
DraftKings is offering $150 in bonus bets for new users who place a $5 wager on the Falcons vs. Packers game.